SM
RXII

Sabby Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Sabby Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,624
Closed -$57K – 363
2016
Q3 		$57K Sell
1,624
-665
-29% -$23.3K ﹤0.01% 295
2016
Q2 		$107K Buy
2,289
+2,054
+874% +$96K 0.01% 263
2016
Q1 		$34K Sell
235
-6,607
-97% -$956K ﹤0.01% 289
2015
Q4 		$1.01M Buy
6,842
+10
+0.1% +$1.47K 0.06% 181
2015
Q3 		$1.08M Hold
6,832
– – 0.04% 223
2015
Q2 		$1.16M Buy
6,832
+60
+0.9% +$10.2K 0.04% 211
2015
Q1 		$941K Buy
6,772
+172
+3% +$23.9K 0.04% 198
2014
Q4 		$997 Sell
6,600
-1,239
-16% -$187 0.03% 158
2014
Q3 		$1.61K Buy
7,839
+683
+10% +$141 0.06% 128
2014
Q2 		$2.19M Sell
7,156
-4,626
-39% -$1.42M 0.09% 99
2014
Q1 		$2.95M Buy
11,782
+2,661
+29% +$665K 0.17% 82
2013
Q4 		$4.52M Buy
9,121
+1,131
+14% +$561K 0.29% 53
2013
Q3 		$1.81M Buy
7,990
+6,699
+519% +$1.52M 0.12% 89
2013
Q2 		$287K Buy
+1,291
New +$287K 0.02% 161

Sabby Management's RXII Position: Q4 2016 in Review

Sabby Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 141,000 shares — an estimated $49K sold.

Sabby Management first reported a position in RXII in Q1 2014 and held it in 7 quarters. The position peaked at $4.78M in Q1 2015. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Sabby Management reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Sabby Management sold 141,000 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $49K.
  • Sabby Management first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 7 quarters.
  • Sabby Management's GALENA BIOPHARMA INC COM position peaked at $4.78M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.